Titlebook: Antiplatelet and Anticoagulation Therapy; Albert Ferro,David A. Garcia Book 2013 Springer-Verlag London 2013 Anticoagulation Therapy.Antip

Johnson

書(shū)目名稱(chēng)Antiplatelet and Anticoagulation Therapy影響因子(影響力)




書(shū)目名稱(chēng)Antiplatelet and Anticoagulation Therapy影響因子(影響力)學(xué)科排名




書(shū)目名稱(chēng)Antiplatelet and Anticoagulation Therapy網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱(chēng)Antiplatelet and Anticoagulation Therapy網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱(chēng)Antiplatelet and Anticoagulation Therapy被引頻次




書(shū)目名稱(chēng)Antiplatelet and Anticoagulation Therapy被引頻次學(xué)科排名




書(shū)目名稱(chēng)Antiplatelet and Anticoagulation Therapy年度引用




書(shū)目名稱(chēng)Antiplatelet and Anticoagulation Therapy年度引用學(xué)科排名




書(shū)目名稱(chēng)Antiplatelet and Anticoagulation Therapy讀者反饋




書(shū)目名稱(chēng)Antiplatelet and Anticoagulation Therapy讀者反饋學(xué)科排名

BARGE

Antiplatelet Drug Resistance and Variability in Response: The Role of Antiplatelet Therapy Monitorieceptor blocker constitutes the mainstay of initial and long-term pharmacologic treatment during acute coronary syndrome and percutaneous coronary interventions. Clopidogrel, the most widely used P2Y12 receptor blocker, therapy is associated with numerous limitations- delayed onset of action, irreve

Supplement

Anticoagulant Drugs: Current and Novel,sed in humans in 1937 and still enjoys widespread use today [1]. During The Great Depression, financially strapped farmers in the Canadian prairies and Northern Plains of the United States were forced to feed their livestock moldy sweet clover hay resulting in the death from internal bleeding of pre

Cubicle

Approaches to the Prophylaxis and Treatment of Venous and Cardiac Thromboembolic Disease,e vessel and its surroundings; (2) Phenomena due to blood coagulation; and (3) Phenomena due to the interruption of the blood stream [1]. An updated description of these factors is: (1) Alteration in blood flow (i.e. stasis); (2) Vascular endothelial injury; and (3) Hypercoagulability. Clot formatio

慟哭

2946-8183 tent approach to each topic in the series.Each volume is designed to be between 120 and 250 pages containing practical illustrations and designed to improve understand and practical usage of cardiovascular drugs in specific clinical areas.978-1-4471-4296-6978-1-4471-4297-3Series ISSN 2946-8183 Series E-ISSN 2946-8191

裝勇敢地做

Glaci冰

Surface Brillouin and Raman Scatteringr-weight heparin (LMWH) was introduced into widespread use in the mid 1990s. Since then, several new anticoagulants including argatroban, bivalirudin, lepirudin, fondaparinux, dabigatran, and rivaroxaban have become available, with numerous others likely to be marketed in the near future.

獨(dú)裁政府

Antiplatelet Agents: Current and Novel,table candidates for development. This chapter describes the pharmacology of those antiplatelet agents that a physician is likely to encounter in clinical practice both now and in the foreseeable future.

helper-T-cells

執(zhí)

Book 2013-nonsense format. The emphasis will be on a just-the-facts clinical approach, heavy on tabular material, light on dense prose.The involvement of the ISCP will ensure that the best quality contributors will be involved and establish a consistent approach to each topic in the series.Each volume is des